Effect of Stimulants on Height and Weight: A Review of the Literature

Dr. Faraone is with the Departments of Psychiatry and Neuroscience and Physiology, SUNY Upstate Medical University; Drs. Biederman and Spencer are with the Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Pediatric Psychopharmacology Unit, Yawkey Center for Outpatient Care; and Dr. Morley is with the Department of Family Medicine, SUNY Upstate Medical University

Accepted 1 April 2008.

Disclosure: Dr. Faraone receives research support and honoraria from, is on the speakers' bureaus of, and has had an advisory or consulting relationship with McNeil Pediatrics, Pfeizer, and Shire Laboratories; he also has had an advisory or consulting relationship with Novartis and Eli Lilly. Dr. Spencer has received research support from, is a speaker for, or is on the advisory boards of Shire Laboratories, Eli Lilly, GlaxoSmithKline, McNeil Pharmaceutical, Novartis Pharmaceuticals, New River Pharmaceuticals, Pfizer, Cephalon, and the National Institute of Mental Health (NIMH). Dr. Biederman has received research support from, is a speaker for, or is on the advisory boards of Shire, Eli Lilly, Pfizer, McNeil, Abbott, Bristol-Myers Squibb, New River Pharmaceuticals, Cephalon, UCB Pharma, Janssen, Neurosearch, Stanley Medical Institute, Novartis, Lilly Foundation, Prechter Foundation, AstraZeneca, Forest Laboratories, GlaxoSmithKline, NIMH, National Institute of Child Health and Development, and the National Institute of Drug Abuse. Mr. Morley reports no conflicts of interest.

• Abstract
• Full Text
• PDF
• Images
• References